1. Home
  2. UNTY vs SCTX Comparison

UNTY vs SCTX Comparison

Compare UNTY & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

SELL

Current Price

$56.23

Market Cap

555.8M

Sector

Finance

ML Signal

SELL

Logo Scribe Therapeutics Inc. Common Stock

SCTX

Scribe Therapeutics Inc. Common Stock

N/A

Current Price

$19.95

Market Cap

536.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UNTY
SCTX
Founded
1991
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
555.8M
536.5M
IPO Year
2014
2026

Fundamental Metrics

Financial Performance
Metric
UNTY
SCTX
Price
$56.23
$19.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
★ $68.60
$57.00
AVG Volume (30 Days)
46.4K
★ 513.6K
Earning Date
10-13-2026
11-29-2026
Dividend Yield
★ 1.21%
N/A
EPS Growth
★ 39.66
N/A
EPS
★ 2.82
N/A
Revenue
N/A
N/A
Revenue This Year
$7.54
N/A
Revenue Next Year
$9.69
N/A
P/E Ratio
$19.88
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.34
$13.50
52 Week High
$62.50
$39.60

Technical Indicators

Market Signals
Indicator
UNTY
SCTX
Relative Strength Index (RSI) 49.09 43.87
Support Level $53.13 $19.09
Resistance Level $57.12 $26.50
Average True Range (ATR) 1.29 2.58
MACD 0.20 0.33
Stochastic Oscillator 68.59 62.93

Price Performance

Historical Comparison
UNTY
SCTX

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. The Company has elected to become a financial holding company pursuant to regulations of the Board of Governors of the Federal Reserve System (the FRB). The Company's primary business is ownership and supervision of the Bank. The Company and the Bank derive a majority of their revenue from net interest income (i.e., the difference between the interest received on loans and securities and the interest paid on deposits and borrowings). The Company, through the Bank, conducts a traditional and community-oriented commercial banking business and services, personal and business checking accounts, time deposits, money market accounts, savings accounts, credit cards, automated teller service, and others.

About SCTX Scribe Therapeutics Inc. Common Stock

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Share on Social Networks: